⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Equitable Technologies Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Equitable Technologies Inc.
↗Boston, USA
Equitable Technologies is a health-tech company that develops non-invasive, AI-assisted diagnostic solutions, specifically focusing on colorectal cancer screening. Their flagship product, 'Peek', is a capsule-based system that captures internal gastrointestinal images and transmits them to a smartphone app for clinician review.
The company aims to make disease screening more affordable, accessible, and accurate by reducing the need for invasive procedures and streamlining the review process for clinicians. They maintain a global presence with offices in Boston (HQ), Kuala Lumpur, and Hyderabad.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Gastrointestinal Diagnostics / HealthTech
SIZE & FINANCIALS
Employees:1-50
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic Device)
Modalities:Digital Health, AI/ML, Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Dana-Farber Cancer Institute (Research/Clinical collaboration)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Krispian Lawrence - Founder
Scientific Founders:Krispian Lawrence
LINKS
Website:screenwithpeek.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Equitable Technologies Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.